|
|
||||||||






* Institute of Enzymology, Biological Research Center, Hungarian Academy of Sciences, Budapest, Hungary;
Medical Research Council Immunochemistry Unit, Department of Biochemistry, University of Oxford, Oxford, United Kingdom;
Analysis-Synthesis Center, Agricultural Biotechnology Center, Gödöllõ, Hungary;
Department of Biochemistry, Eötvös Loránd University, Budapest, Hungary; and
¶ Department of Microbiology and Immunology, University of Leicester, Leicester, United Kingdom
Mannan-binding lectin-associated serine protease (SP) (MASP)-1 and MASP-2 are modular SP and form complexes with mannan-binding lectin, the recognition molecule of the lectin pathway of the complement system. To characterize the enzymatic properties of these proteases we expressed their catalytic region, the C-terminal three domains, in Escherichia coli. Both enzymes autoactivated and cleaved synthetic oligopeptide substrates. In a competing oligopeptide substrate library assay, MASP-1 showed extreme Arg selectivity, whereas MASP-2 exhibited a less restricted, trypsin-like specificity. The enzymatic assays with complement components showed that cleavage of intact C3 by MASP-1 and MASP-2 was detectable, but was only
0.1% of the previously reported efficiency of C3bBb, the alternative pathway C3-convertase. Both enzymes cleaved C3i 10- to 20-fold faster, but still at only
1% of the efficiency of MASP-2 cleavage of C2. We believe that C3 is not the natural substrate of either enzyme. MASP-2 cleaved C2 and C4 at high rates. To determine the role of the individual domains in the catalytic region of MASP-2, the second complement control protein module together with the SP module and the SP module were also expressed and characterized. We demonstrated that the SP domain alone can autoactivate and cleave C2 as efficiently as the entire catalytic region, while the second complement control protein module is necessary for efficient C4 cleavage. This behavior strongly resembles C1s. Each MASP-1 and MASP-2 fragment reacted with C1-inhibitor, which completely blocked the enzymatic action of the enzymes. Nevertheless, relative rates of reaction with
-2-macroglobulin and C1-inhibitor suggest that
-2-macroglobulin may be a significant physiological inhibitor of MASP-1.
This article has been cited by other articles:
![]() |
M. Megyeri, V. Mako, L. Beinrohr, Z. Doleschall, Z. Prohaszka, L. Cervenak, P. Zavodszky, and P. Gal Complement Protease MASP-1 Activates Human Endothelial Cells: PAR4 Activation Is a Link between Complement and Endothelial Function J. Immunol., September 1, 2009; 183(5): 3409 - 3416. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dobo, V. Harmat, L. Beinrohr, E. Sebestyen, P. Zavodszky, and P. Gal MASP-1, a Promiscuous Complement Protease: Structure of Its Catalytic Region Reveals the Basis of Its Broad Specificity J. Immunol., July 15, 2009; 183(2): 1207 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Thiel, M. Kolev, S. Degn, R. Steffensen, A. G. Hansen, M. Ruseva, and J. C. Jensenius Polymorphisms in Mannan-Binding Lectin (MBL)-Associated Serine Protease 2 Affect Stability, Binding to MBL, and Enzymatic Activity J. Immunol., March 1, 2009; 182(5): 2939 - 2947. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Takahashi, D. Iwaki, K. Kanno, Y. Ishida, J. Xiong, M. Matsushita, Y. Endo, S. Miura, N. Ishii, K. Sugamura, et al. Mannose-Binding Lectin (MBL)-Associated Serine Protease (MASP)-1 Contributes to Activation of the Lectin Complement Pathway J. Immunol., May 1, 2008; 180(9): 6132 - 6138. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rawal, R. Rajagopalan, and V. P. Salvi Activation of Complement Component C5: COMPARISON OF C5 CONVERTASES OF THE LECTIN PATHWAY AND THE CLASSICAL PATHWAY OF COMPLEMENT J. Biol. Chem., March 21, 2008; 283(12): 7853 - 7863. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Moller-Kristensen, S. Thiel, A. Sjoholm, M. Matsushita, and J. C. Jensenius Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway Int. Immunol., February 1, 2007; 19(2): 141 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Iwaki, K. Kanno, M. Takahashi, Y. Endo, N. J. Lynch, W. J. Schwaeble, M. Matsushita, M. Okabe, and T. Fujita Small Mannose-Binding Lectin-Associated Protein Plays a Regulatory Role in the Lectin Complement Pathway J. Immunol., December 15, 2006; 177(12): 8626 - 8632. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Roos, M. P. Rastaldi, N. Calvaresi, B. D. Oortwijn, N. Schlagwein, D. J. van Gijlswijk-Janssen, G. L. Stahl, M. Matsushita, T. Fujita, C. van Kooten, et al. Glomerular Activation of the Lectin Pathway of Complement in IgA Nephropathy Is Associated with More Severe Renal Disease J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1724 - 1734. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Arnold, R. Wallis, A. C. Willis, D. J. Harvey, L. Royle, R. A. Dwek, P. M. Rudd, and R. B. Sim Interaction of Mannan Binding Lectin with {alpha}2 Macroglobulin via Exposed Oligomannose Glycans: A CONSERVED FEATURE OF THE THIOL ESTER PROTEIN FAMILY? J. Biol. Chem., March 17, 2006; 281(11): 6955 - 6963. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Rossi, F. Teillet, N. M. Thielens, I. Bally, and G. J. Arlaud Functional Characterization of Complement Proteases C1s/Mannan-binding Lectin-associated Serine Protease-2 (MASP-2) Chimeras Reveals the Higher C4 Recognition Efficacy of the MASP-2 Complement Control Protein Modules J. Biol. Chem., December 23, 2005; 280(51): 41811 - 41818. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Seyfarth, P. Garred, and H. O. Madsen The 'involution' of mannose-binding lectin Hum. Mol. Genet., October 1, 2005; 14(19): 2859 - 2869. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gal, V. Harmat, A. Kocsis, T. Bian, L. Barna, G. Ambrus, B. Vegh, J. Balczer, R. B. Sim, G. Naray-Szabo, et al. A True Autoactivating Enzyme: STRUCTURAL INSIGHT INTO MANNOSE-BINDING LECTIN-ASSOCIATED SERINE PROTEASE-2 ACTIVATIONS J. Biol. Chem., September 30, 2005; 280(39): 33435 - 33444. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Teillet, B. Dublet, J.-P. Andrieu, C. Gaboriaud, G. J. Arlaud, and N. M. Thielens The Two Major Oligomeric Forms of Human Mannan-Binding Lectin: Chemical Characterization, Carbohydrate-Binding Properties, and Interaction with MBL-Associated Serine Proteases J. Immunol., March 1, 2005; 174(5): 2870 - 2877. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Windbichler, B. Echtenacher, T. Hehlgans, J. C. Jensenius, W. Schwaeble, and D. N. Mannel Involvement of the Lectin Pathway of Complement Activation in Antimicrobial Immune Defense during Experimental Septic Peritonitis Infect. Immun., September 1, 2004; 72(9): 5247 - 5252. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Boshra, A. E. Gelman, and J. O. Sunyer Structural and Functional Characterization of Complement C4 and C1s-Like Molecules in Teleost Fish: Insights into the Evolution of Classical and Alternative Pathways J. Immunol., July 1, 2004; 173(1): 349 - 359. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-B. Chen and R. Wallis Two Mechanisms for Mannose-binding Protein Modulation of the Activity of Its Associated Serine Proteases J. Biol. Chem., June 18, 2004; 279(25): 26058 - 26065. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. G. Ma, M. Y. Cho, M. Zhao, J. W. Park, M. Matsushita, T. Fujita, and B. L. Lee Human Mannose-binding Lectin and L-Ficolin Function as Specific Pattern Recognition Proteins in the Lectin Activation Pathway of Complement J. Biol. Chem., June 11, 2004; 279(24): 25307 - 25312. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zundel, S. Cseh, M. Lacroix, M. R. Dahl, M. Matsushita, J.-P. Andrieu, W. J. Schwaeble, J. C. Jensenius, T. Fujita, G. J. Arlaud, et al. Characterization of Recombinant Mannan-Binding Lectin-Associated Serine Protease (MASP)-3 Suggests an Activation Mechanism Different from That of MASP-1 and MASP-2 J. Immunol., April 1, 2004; 172(7): 4342 - 4350. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sprong, P. Brandtzaeg, M. Fung, A. M. Pharo, E. A. Hoiby, T. E. Michaelsen, A. Aase, J. W. M. van der Meer, M. van Deuren, and T. E. Mollnes Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis Blood, November 15, 2003; 102(10): 3702 - 3710. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |